A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Recruiting now · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma

In brief

Study to investigate the efficacy, safety and tolerability of systemic chemotherapy plus ponsegromab versus systemic chemotherapy plus placebo for the first-line treatment in adult participants with cachexia and metastatic pancreatic ductal adenocardinoma.

Key facts

Study ID
NCT06989437
Run by
Pfizer
People needed
982
Starts
2025-10-03
Expected to finish
2029-12-10
Last updated by the study team
2026-07-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.